What Is an LP Advisory Board (LPAC) in a Private Equity Fund? Powers, Limits, and Why It Matters

TL;DR: An LP Advisory Board (LPAC) is a small committee of limited partner representatives that a private equity fund's general partner must consult — and sometimes get approval from — when conflicts of interest arise; but because LPAC members usually owe no formal fiduciary duty to other LPs and the GP controls the agenda and information flow, the ILPA warns that an LPAC's approval is only as reliable as the process behind it.

What an LPAC Is and How Members Get Chosen

Start with the basics. A limited partnership agreement (LPA) is the founding contract of a private equity fund , it sets out what the general partner (GP) can do, what limited partners (LPs) own, and how conflicts get handled. Most institutional-grade LPAs create a Limited Partner Advisory Committee, commonly called the LPAC or LP Advisory Board. This is a standing committee made up of LP representatives who serve as a check on the GP between annual meetings.

The GP typically selects LPAC members at fund formation. Selection is not democratic. The GP invites its largest or most strategically important investors, and those investors accept seats as a condition of their commitment. Morgan Lewis's VC and PE Funds Deskbook recommends a minimum of 3 and a maximum of 9 voting members to keep the body functional. The GP typically chairs meetings without a vote. All voting seats must go to LP representatives with no affiliation to the GP , that independence requirement is the structural protection that makes the committee meaningful in theory.

Most LPs in a fund never sit on the LPAC. A fund with 80 limited partners might seat 5 on the committee. That concentration of representation matters a great deal when the LPAC is voting on something that affects every dollar in the fund.

What an LPAC Can Actually Do

The LPAC's authority comes in three main forms: conflict waivers, structural approvals, and oversight of major personnel events.

Conflict waivers are the most common use. When a GP wants to invest fund capital in a deal where it or an affiliate has a competing interest, the LPA usually requires the LPAC to review the transaction and formally waive the conflict. Without that waiver, the GP risks breach of the fund agreement. In practice, LPAC members review a conflict disclosure memo, ask questions, and vote yes or no.

Structural approvals cover bigger events. GP-led secondary transactions , where the GP transfers one or more portfolio companies into a new vehicle called a continuation fund , almost always require LPAC sign-off. A continuation fund is a new legal entity the GP creates to hold assets longer than the original fund's term allows. Existing LPs face a binary choice: roll their interest into the new vehicle or sell to a secondary buyer. Because the GP sits on both sides of that transaction (seller of the old fund's assets, buyer into the new fund), the conflict is severe. That is exactly why LPAC approval is mandatory under most LPAs and why ILPA's May 2023 continuation fund guidance dedicates an entire section to LPAC process requirements.

Key-person events are the third category. When a named senior professional leaves or is unable to perform duties, many LPAs trigger a "key-person event" that suspends new investments until the LPAC approves either a replacement or a plan to continue. The LPAC acts as a circuit breaker on capital deployment while the GP sorts out its leadership.

What an LPAC Can Do	What an LPAC Cannot Do
Review and approve (or reject) conflict-of-interest transactions	Direct the GP on investment decisions or portfolio management
Waive conflicts formally so the GP can proceed	Override the GP's authority under the LPA on non-conflict matters
Approve continuation fund and GP-led secondary transactions	Sue the GP on behalf of other LPs (absent express LPA language)
Consent to key-person replacements and restart investments	Compel the GP to share information beyond what the LPA requires
Negotiate LPA amendments with the GP	Represent or bind LPs who are not on the committee

The Real Legal Limits , and Why Most Explainers Skip Them

Here is where I part ways with most glossary entries. The standard write-up tells you what an LPAC does. I want to tell you what it cannot do, because that is what actually protects , or fails to protect , your investment.

First, the fiduciary duty gap. Fiduciary duty is the legal obligation to act in another party's best interest. GPs owe a fiduciary duty to the fund. LPAC members, by contrast, generally do not owe a fiduciary duty to the broader LP base unless the LPA explicitly says they do. Morgan Lewis's guidance notes that LPAC members who approve conflicted transactions can become fiduciaries to other LPs even absent express LPA language , but that outcome depends on facts and circumstances, not on a clean rule. The ILPA echoes this concern. An LP who is not on the LPAC and believes the committee approved a bad transaction has no clean legal path to challenge it.

Second, the GP controls the agenda. The GP decides which conflicts get brought to the LPAC, when they get scheduled, and what information goes into the disclosure memo. An LPAC can only evaluate what it sees. If the GP structures a disclosure to emphasize favorable projections and bury adverse assumptions, the LPAC may approve a transaction it would have rejected with full information. The ILPA specifically discourages GPs from conducting one-on-one outreach to individual LPAC members outside full committee meetings , a practice that can fragment the committee's deliberation and push members toward approval before they have coordinated their views.

Third, approval thresholds can be thin. Many LPAs require only a majority vote, sometimes a simple majority of a quorum. In a 7-member LPAC, that can mean 4 votes. Those 4 votes can commit a fund with hundreds of millions of LP capital to a transaction the other 3 members opposed and the non-member LPs never got to weigh in on.

What ILPA Says a Well-Run LPAC Should Look Like

The Institutional Limited Partners Association (ILPA) is the main industry body representing LP interests globally , nearly 600 member organizations representing over $2 trillion in private equity assets under management. Its Private Equity Principles v2.0 and its 2023 continuation fund guidance set the benchmark for LPAC governance.

On timing: ILPA recommends LPs get at least 30 calendar days (or 20 business days) to make roll-or-sell decisions in continuation fund transactions, and LPAC members get at least 10 business days to evaluate and vote on conflict waivers. Compressing those windows is a red flag.

On process: ILPA says the GP should bring all material conflicts to the LPAC as a body , no divide-and-conquer calls with individual members before the formal meeting. It also recommends the LPAC retain independent legal counsel paid by the fund, not the GP, so the committee is not reading analysis from advisors who depend on GP relationships for future work.

On economic alignment in continuation funds: as Ropes & Gray summarizes the ILPA guidance, virtually all crystallized carried interest , the GP's profit share that has vested on the assets being transferred , should roll into the new vehicle rather than be paid out. That standard preserves GP-LP alignment by keeping the GP's economics tied to the same assets from here. A GP that insists on cashing out carried interest at the point of transfer is removing the incentive to generate further appreciation in the continuation fund.

The ILPA also recommends that LPAs include express language clarifying that LPAC approval of a specific conflict does not constitute a blanket waiver of future conflicts of the same type. Pre-clearing conflict categories in advance is a GP-favorable practice that ILPA discourages. Debevoise & Plimpton's summary of that guidance confirms that even where LPAs contain anticipatory waivers, ILPA expects the LPAC to evaluate each specific conflict on its merits.

ADIC v. EMG: What Happens When Best Practices Are Ignored

Abstract principles are useful. A real case is better.

In December 2025, Abu Dhabi Investment Council Company PJSC (ADIC) filed a verified complaint in the Delaware Court of Chancery against The Energy & Minerals Group LP (EMG) over EMG's transfer of its Ascent Resources investment into a new vehicle called EMG Ascent Continuation Fund LP. The complaint (C.A. No. 2025-1389-NAC) alleges that EMG sought Advisory Board approval for the continuation fund transaction but only 3 of 43 Advisory Board members voted in favor. EMG nonetheless characterized the vote as approval and proceeded to distribute LP election forms asking investors to choose between rolling into the new vehicle or selling out.

That 3-out-of-43 approval figure is not a typo. If accurate, it represents one of the thinnest claimed approval thresholds I have seen cited in public litigation. The case raises the exact issues ILPA's guidance is designed to prevent: whether the approval process was conducted through proper collective deliberation, whether LPs received adequate information and time, and whether an approval claimed on those facts should bind the fund's other investors.

The case was still in early stages as of this writing. But the complaint itself is instructive regardless of outcome. It shows that LPAC mechanics , quorum requirements, voting thresholds, information disclosure procedures , are not administrative formalities. They are the difference between a legitimate conflict resolution and a process that exposes the GP and LPAC members to litigation.

What This Means If You Are an Emerging Fund Manager

If you are raising your first or second fund, you will almost certainly form an LPAC when your LPA requires one. Here is what I tell emerging managers: treat the LPAC as a real governance body, not a rubber-stamp committee you check off to satisfy your legal team.

Choose members who will push back. A seasoned LP on your LPAC who asks hard questions before approving a conflict waiver is protecting you from a future lawsuit as much as they are protecting their co-investors. Give them adequate notice , at minimum the ILPA's 10 business days , and provide written conflict disclosures that an outside reader could evaluate fairly. Keep full meeting minutes. Avoid calling individual members before the formal meeting to line up votes.

If your LPA contains a broad anticipatory conflict waiver, ask your counsel whether you should bring specific transactions to the LPAC anyway. The answer, consistent with ILPA guidance and basic risk management, is almost always yes.

Frequently Asked Questions

Is the LPAC the same as the fund's board of directors?

No. A corporation's board of directors has statutory authority and owes fiduciary duties to shareholders. An LPAC is a contractual creation of the LPA with only the powers that document grants it. LPAC members do not automatically owe fiduciary duties to other LPs, the committee cannot sue the GP on behalf of the fund, and it has no authority over day-to-day investment decisions. Calling it a board overstates its structural power.

Do I get to vote on who sits on the LPAC?

In most funds, no. The GP selects LPAC members, typically from its largest LP relationships. You can try to negotiate LPAC membership as a condition of your commitment , large institutional investors do this regularly , but standard LPAs give the GP broad discretion over seat selection. If LPAC representation matters to you as an LP, raise it during the subscription negotiation, not after the fund closes.

If the LPAC approves a transaction I think is bad, what can I do?

Your options are limited by what your LPA says. In most funds, an LPAC approval is binding on non-member LPs for the conflict it covers, and absent express LPA language giving you standing to challenge, your primary contractual remedy is withdrawal or transfer of your interest , neither of which is easy or cheap in a private fund. This is why LPA negotiation before you commit matters far more than most first-time LP investors realize. Review the conflict of interest, LPAC approval, and limited partner remedy provisions of the LPA before you wire your commitment.

What is a continuation fund, and why does the LPAC matter so much in that context?

A continuation fund (also called a GP-led secondary) is a new vehicle the GP creates to hold one or more portfolio companies beyond the original fund's investment term. Because the GP is on both sides of the transaction , selling assets out of the old fund and buying them into the new one at the same time , the conflict of interest is direct and severe. The LPAC's approval is the primary structural check on that conflict for investors who remain in the old fund. Without a credible, well-documented LPAC process, existing LPs have little protection against a GP that prices the transfer to favor its own economics in the new vehicle over fair value for the old fund's sellers.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.